NCT00812188View on ClinicalTrials.gov

Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Symmetric Limited Morphea
Interventions
OTHER

Medium Dose UVA-1

UVA-1 phototherapy treatment (60 J/cm2) three times per week for 12 weeks.

OTHER

High Dose UVA-1

High dose (120 J/cm2)UVA-1 phototherapy three times per week for 12 weeks.

Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas - Department of Dermatology Clinical Trials, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT00812188 - Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea. | Biotech Hunter | Biotech Hunter